Our Story

Vidiia was born to meet the need for rapid, cost-effective, on-site diagnostics, as highlighted by the challenges posed during the COVID-19 pandemic. The global crisis exposed significant gaps in testing capacity, emphasising the importance of portable, reliable diagnostics that can deliver results quickly without relying on centralised labs.

A collaboration between the University of Surrey, Lancaster University and Brunel University London, combined technologies leading to the spin out of Vidiia, formed to translate their existing LAMP technologies for a BBRSC funded project targeting the poultry industry in the Philippines, into a COVID-19 test.The research paper, published on the COVID-19 work, (10.3389/fmolb.2023.1144001) underscores how the pandemic accelerated the demand for innovative diagnostic tools, offering solutions that combine speed, affordability, and accessibility, addressing critical testing bottlenecks experienced during COVID-19 and paving the way for broader diagnostic applications.

In a short space of time, the COVID-19 test was developed and its high sensitivity (98%) and specificity (100%) got it approved by the UK government, under the Medical Devices Coronavirus Test Device Approvals Regulations. 

Following the successful development and validation of the COVID-19 test on our platform, Vidiia have actively engaged with researchers to uncover multiple other assays, of which are at varying stages of Vidiia’s Assay Accelerator programme.

Our Ambitions

100 Assays Through Our Assay Accelerator by 2029

Vidiia is transforming assay development and on-site diagnostics with innovative AI technology. By 2029, we aim to accelerate 100 assays through our Assay Accelerator.Our platform leverages AI to turn academic research into impactful, cost-effective diagnostics, identifying and unlocking dormant or unknown assays.

We are committed to democratising diagnostic testing with low-cost, portable, AI-powered solutions that can be used anywhere, by anyone.Vidiia identify the need to bridge research and real-world application, enhancing efficiency and ensuring global accessibility, setting new industry standards in diagnostic innovation.